ArticleSocial psychiatry and psychiatric epidemiology2026
Cognitive impairment and associated factors among patients with mood disorders receiving care at public hospitals in Gedeo zone, Southern Ethiopia.
Article in Social psychiatry and psychiatric epidemiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCognitive impairment is characterized by difficulty in attention, memory, problem-solving, and decision-making. It is strongly linked to mood disorders and affects work performance, social interactions, medication adherence, and overall quality of life. Despite the high burden of the problem, evidence on its prevalence and contributing factors remains scarce in low- and middle-income countries. This study aimed to determine the prevalence and associated factors of cognitive impairment among individuals with mood disorders.
methodA cross-sectional study was conducted at Gedeo Zone public hospitals. A systematic sampling technique was used to select a total of 422 individuals receiving care for mood disorders. The outcome variable was assessed using the Montreal Cognitive Assessment (MoCA). The data were entered into Epi Data version 4.2 and analyzed using STATA version 17. Bivariable and multivariable logistic regression analyses were performed to identify factors associated with cognitive impairment. The presence of an association was examined with an adjusted odd ratio with a 95% confidence interval and variables with P values less than 0.05 were considered a statistically significant association.
resultThe prevalence of cognitive impairment among individuals with bipolar disorders and depressive disorders was 34.5% (95% CI: 32.7-36.9) and 38.7% (95% CI: 36.4-40.8), respectively. Having a longer duration of treatment [AOR = 1.87 (95% CI: 1.57, 2.94)], a duration of illness 10 years and above [AOR = 2.13 (95% CI 1.23, 4.48)], and severe depressive symptoms [AOR = 2.15 (95% CI 1.14, 4.97)] were significantly associated with cognitive impairment among individuals with depressive disorders. Medication non-adherence [AOR = 1.48 (95% CI: 1.34, 2.78)], a long duration of illness [AOR = 1.42 (95% CI: 1.09, 2.48)], and severe manic symptoms [AOR = 2.16 (95% CI: 1.18, 5.28)] were significantly associated with cognitive impairment among participants with bipolar disorders.
conclusionThis study revealed a high prevalence of cognitive impairment in patients with mood disorders. Therefore, early screening and intervention for cognitive impairment in mood disorder patients are essential to deliver holistic care and improve treatment outcomes. Integrating cognitive assessments into routine mental health evaluations can help identify early deficits and enable tailored interventions. Additionally, cognitive remediation strategies such as structured patient education, side-effect management, and medication adjustments should be prioritized to enhance adherence and overall recovery.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.